BioTuesdays

Author - Abby Hardy

Chimerix appoints Allen Melemed as CMO

Chimerix (NASDAQ:CMRX) appointed Dr. Allen Melemed as its CMO. Dr. Melemed was most recently a distinguished medical fellow and senior director of North American regulatory affairs oncology at Eli Lilly (NYSE:LLY). He...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.